Latest filing published 03 Mar 2023 for CONMED Corp.
Insider track record
Jaclyn Peterson: trading record in brief
Jaclyn Peterson (chief executive) discloses dealings in CONMED Corp to SEC (Form 4). In total, 5 filings cover trades dated from 31 December 2021 to 1 March 2023.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 3 March 2023 with an option exercise in CONMED Corp. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jaclyn Peterson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 250 shares0Common StockSEC:0001127602-23-008541:0
- 154 shares@ US$109.31Common StockSEC:0001127602-22-014261:1
- 500 shares0Common StockSEC:0001127602-22-014261:0
- 169 shares@ US$141.1273.9% of flowCommon StockSEC:0001127602-22-011219:0
- 64 shares@ US$134.6726.1% of flowCommon StockSEC:0001127602-22-000862:0
5 of 5 declarations
